Sharechat Logo

National Australia Bank may make further provision for CDOs

Friday 11th July 2008

Text too small?
National Australia Bank (NAB), Australia's biggest lender and the owner of Bank of New Zealand, said it may have to make a further provision for its exposure to collateral debt obligations.

The bank established a provision of A$181 million on March 31 after disclosing an exposure to US$1.1 billion of CDOs via the provision of liquidity lines to conduit financing vehicles. CDOs are securities backed by a pool of bonds, loans and other assets.

Since March, "the economic environment has deteriorated further," NAB said in a statement. "There continues to be a risk that further provisioning may be required."

The global credit crunch left banks with losses from CDOs as credit ratings were slashed and sapped demand for the securities. The volume of CDOs sold in the first half of the year amounts to just 10% of sales in the same period of 2007, the Financial Times reported, citing data from Dealogic and Total Securitization.

NAB said the CDOs it is exposed to are currently meeting their principal and interest obligations.

Shares of NAB have declined about 22% on the ASX this year and were recently at A$27.28.

By Jonathan Underhill



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors